7.000
−13,58%
2026-10-19
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +140.5% | -121.1% | 1 / 3 | -44.7% | -115.19 pp | +281.25 pp | -9.1% | 0.11 | — | 3,9 | −44,7% | 4,6 | +140,5% | — | -3.83 | — |
| Pts | 12 | 0 | 4 | 0 | 0 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 7.000 (close price on 2026-10-19)EPS (TTM): −988,6
Financial charts
1.Revenue & growth
VND bn3,89Q2/26
1.Revenue & growth
VND bn3,89Q2/26
2.Profit & growth
VND bn4,62Q2/26
3.Profit mix (Penman)
VND bn-12,7Q2/26
4.Margins & cost structure
%-40.8%Q2/26
5.Returns & cash cycle
% · days-12.8%Q2/26
6.Earnings quality & cash
VND bn-8,17Q2/26
7.Asset structure
VND bn217Q2/26
8.Funding & debt health
VND bn · times217Q2/26
9.Revenue backlog
VND bn2,96Q2/26
10.Valuation
times · %-8,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %360Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26